Sasaki, Eita
Asanuma, Hideki
Momose, Haruka
Maeyama, Jun–ichi
Moriyama, Saya
Nagata, Noriyo
Suzuki, Tadaki
Hamaguchi, Isao
Hasegawa, Hideki
Takahashi, Yoshimasa
Funding for this research was provided by:
The Japan Agency for Medical Research and Development (JP19ak0101071)
Japan Society for the Promotion of Science KAKENHI (19K12873)
Article History
Received: 28 October 2024
Accepted: 4 February 2025
First Online: 11 February 2025
Competing interests
: E.S. and I.H. are named as inventors on a patent (P7157288) claiming the use of vaccine adjuvant screening and a safety assessment method using the biomarker genes filed by the National Institute of Infectious Diseases. E.S. and Y.T. declare that an intellectual property application has been filed using the data presented in this paper. The other authors declare that they have no competing interests.